Literature DB >> 11185606

Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients.

S J Singer, R Tiernan, E J Sullivan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11185606     DOI： 10.1056/nejm200012143432417

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS.

Authors:  Heth R Turnquist; Jon Cardinal; Camila Macedo; Brian R Rosborough; Tina L Sumpter; David A Geller; Diana Metes; Angus W Thomson
Journal:  Blood       Date:  2010-03-24       Impact factor: 22.113

2.  Comprehensive lung injury pathology induced by mTOR inhibitors.

Authors:  Guadalupe Aparicio; Moisés B Calvo; Vanessa Medina; Ovidio Fernández; Paula Jiménez; Martina Lema; Angélica Figueroa; Luis M Antón Aparicio
Journal:  Clin Transl Oncol       Date:  2009-08       Impact factor: 3.405

3.  Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.

Authors:  Haishan Li; C David Pauza
Journal:  Cancer Immunol Immunother       Date:  2010-11-25       Impact factor: 6.968

Review 4.  Benefit-risk assessment of sirolimus in renal transplantation.

Authors:  Dirk R J Kuypers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.

Authors:  Martin Rodriguez; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Sirolimus-related pulmonary toxicity mimicking 'asthma like' symptoms.

Authors:  G-L Gupte; S Mahadevan; J-R Clarke; H Alton; S-V Beath
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

7.  IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease.

Authors:  Elizabeth O Stenger; Brian R Rosborough; Lisa R Mathews; Huihui Ma; Markus Y Mapara; Angus W Thomson; Hēth R Turnquist
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-12       Impact factor: 5.742

8.  Activation of MTOR in pulmonary epithelium promotes LPS-induced acute lung injury.

Authors:  Yue Hu; Jian Lou; Yuan-Yuan Mao; Tian-Wen Lai; Li-Yao Liu; Chen Zhu; Chao Zhang; Juan Liu; Yu-Yan Li; Fan Zhang; Wen Li; Song-Min Ying; Zhi-Hua Chen; Hua-Hao Shen
Journal:  Autophagy       Date:  2016-09-22       Impact factor: 16.016

9.  Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus.

Authors:  Veroniek E M Harbers; Gerard A P J M Rongen; Carine J M van der Vleuten; Bas H Verhoeven; Peter C J de Laat; Chantal M A M van der Horst; Willemijn M Klein; Leo J Schultze Kool; D Maroeska W M Te Loo
Journal:  Adv Ther       Date:  2021-05-18       Impact factor: 3.845

10.  Icotinib combined with rapamycin in a renal transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer: A case report.

Authors:  Qiong Zhao; Yina Wang; Yemin Tang; Ling Peng
Journal:  Oncol Lett       Date:  2013-11-05       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.